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Non-protein sulphydryls (NPSH), particularly glutathione, have
been extensively investigated for their role in resistance to
chemotherapy and radiation (Mitchell and Russo, 1987; Coleman
et al, 1988; Biaglow et al, 1989; Bump and Brown, 1990; Tew,
1994). NPSH are believed to be able to interact with radiation-
induced radical sites on DNA to effect their rapid repair (Bump
et al, 1992; Orta et al, 1995). Although glutathione is less efficient
than cysteine, it is usually present at much higher concentrations.
Under aerobic conditions, DNA radical damage tends to become
fixed by the binding of molecular oxygen, rather than repaired by
interaction with NPSH. However, under low oxygen conditions
(hypoxia), NPSH are better able to compete with oxygen for DNA
radical sites, and NPSH concentrations therefore become a more
important determinant of radiation sensitivity (Solen et al, 1989;
Bump et al, 1992; Orta et al, 1995; Prise et al, 1998).
There is good evidence that hypoxic regions exist in some
tumours, and that the presence of hypoxia is an important cause of
radiation resistance in vivo. A number of clinical studies have now
shown that hypoxia is associated with a poor prognosis in human
solid tumours (Brizel et al, 1996, 1997; Hockel et al, 1996).
A recent study from our own institution involving patients with
squamous cell carcinoma of the uterine cervix found that the pres-
ence of hypoxia, as determined using the Eppendorf polarographic
electrode, was associated with an inferior response to radical
radiotherapy (Fyles et al, 1998).
We were interested to know if there is a systematic relationship
between hypoxia and NPSH levels within solid tumours, since this
would be expected to modify the effects of oxygen on in vivo
radiosensitivity. Recently it has become possible to identify
regions of hypoxia in histological sections of solid tumours, using
immunofluorescence detection of the binding of nitroimidazole
compounds that undergo bioreduction to reactive intermediaries
under hypoxic conditions (Lord et al, 1993). In this paper we
describe a modification of this technique involving dual-labelling
with the sulphydryl-reactive stain mercury orange. Stained cryo-
stat sections obtained from human cervical cancer xenografts were
examined, using a fluorescence image analysis system that is
capable of mapping the whole cut surface of the tumour. Results
using this technique show that NPSH levels are elevated in regions
of hypoxia, suggesting that this might exacerbate the effects on
radioresistance in vivo.
MATERIALS AND METHODS
Establishment of human cervical carcinoma xenografts
The human cervical squamous cell carcinoma cell lines ME180
and SiHa were obtained from ATCC. Xenografts were established
in severe combined immunodeficient (SCID) mice by injecting
the right gastrocnemius muscle with a cell suspension containing
2 ´ 106 cells. The tumours were allowed to grow to a size of
10–12 mm in external thigh diameter.
The fluorinated nitroimidazole compound EF5 (2-(2-nitro-1H-
imidazol-l-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide) was a
gift of Dr Cameron Koch, University of Pennsylvania (Lord et al,
1993). It was made up as a 10 mM solution in 0.9% saline, and
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Correspondence to: DW Hedleyinjected at a dose of 1% of body weight via a tail vein 3 h before
excising the tumours. One mouse from each group of animals was
used as a control and received no EF5 injection. After excision
the tumours were bisected, placed in a vial containing OCT-
embedding medium (Tissue-Tek, Sakura, USA), and immediately
frozen and stored in liquid nitrogen.
Double fluorescence staining with mercury orange and
anti-EF5
NPSH staining
Tumour tissue sections 4-mm thick were cut using a cryostat at a
chamber temperature of –25°C. The method for staining non-
protein sulphydryls in tissue sections was an adaptation from the
single cell method previously published by our laboratory
(Thomas et al, 1995), and similar to other histochemical tech-
niques based on mercury orange (Asghar et al, 1975; Larrauri
et al, 1987; Philbert et al, 1991). The sulphydryl-reactive
dye 1-(4-chloromercuriphenoylazo)-naphthol-2 (mercury orange;
Sigma, St Louis, MO, USA) was first dissolved in acetone, then
distilled water was added to produce a final concentration of
75 mM in 9:1 (v/v) acetone-water. In order to minimize the loss of
reduced thiols through oxidation, the cryostat sections were imme-
diately stained for 5 min in the mercury orange solution in Coplin
jars placed on ice. They were then rinsed twice with 9:1 acetone-
distilled water, and allowed to air-dry before being fixed in 3.7%
buffered formaldehyde for 10 min and then rinsed with phosphate-
buffered saline (PBS) three times.
Anti-EF5 labelling
The formalin-fixed, mercury orange-stained tissue sections were
first blocked with 20% skimmed milk, 5% mouse serum, 1.5%
albumin and 0.3% Tween. The ELK3-51 monoclonal antibody to
EF5 conjugated to Cy5 was supplied by Dr Cameron Koch,
University of Pennsylvania as a 1.5 mg ml-1 solution, and used at a
dilution of 1:20. The sections were incubated for 1 h and then
rinsed three times with PBS. Finally, the slides were mounted
using Vectorshield mounting medium (Vector Laboratories,
Burlingame, CA).
Immunohistochemical staining with EF5 monoclonal
antibody
Immunohistochemical (IHC) staining for EF5 was done using the
Level 2 Multispecies Ultra Streptavidin Detection System HRP kit
(Signet Laboratories, Dedham, MA, USA). Serial sections to those
used for the fluorescence staining method were air-dried, fixed for
10 min in 3.7% formol PBS, and rinsed three times in PBS.
Endogenous peroxidases were quenched using 0.3% hydrogen
peroxide for 10 min. After rinsing with PBS sections were blocked
as for the immunofluorescence anti-EF5 method. The sections
were then incubated for 1 h with a biotinylated anti-EF5 mono-
clonal antibody. After rinsing, the kit link and labelling reagents
were used according to the manufacturer’s instructions. Sections
were then incubated with AEC chromogen for 5 min and counter-
stained with Mayer’s haemalum solution (BDH, Poole, UK).
Computerized image analysis
Transmitted light study
The sections stained with EF5 monoclonal antibody by IHC were
studied using a MicroComputer Image Device (MCID; Imaging
Research Inc., St Catharine’s, Ontario, Canada) linked to a colour
CCD camera (Sony DXC 970 MD) mounted on a transmitted-light
microscope (Zeiss Axioskop) fitted with a Ludl Biopoint motor-
ized stage. Using a 10´ objective and an automated mini program,
a microscopic field by field digitized tiled image of the entire
tumour surface was obtained. These images showing the hypoxic
tumour regions were used as a guide for selecting regions of the
tumour for analysis by fluorescence microscopy, as described
below.
Quantitative fluorescence microscopy
A second MCID image analysis system was used to analyse tissue
sections that were double-labelled with mercury orange and Cy5-
conjugated anti-EF5. This system has similar computer hardware
and software to that used for transmitted light microscopy, linked
to a Xillix MicroImager (Xillix, Vancouver, Canada) mounted on a
reflected fluorescence microscope (Olympus BX50) fitted with a
Ludl Biopoint motorized stage.
Printouts of the immunoperoxidase staining for the entire cut
surface of the tumours were used as maps to select regions encom-
passing approximately 20–30% of the tumour section surface for
analysis. These regions were selected on the basis of consisting
largely of viable tumour tissue containing clearly delineated
hypoxic microregions. Using a 20´, 0.5 N.A. objective lens, tiled
field images of these region were obtained, based on 40–80 indi-
vidual fields. The slide was first scanned using red illumination, to
show the areas of hypoxia as detected by the Cy5 conjugated 
anti-EF5 antibody. Next, a tiled field image of the same regions
was obtained using an excitation filter centred at 540 nm which
optimally excites mercury orange. Fluorescence emission was
collected using a 585/40 nm bandpass filter. To study the relation-
ship between hypoxia and levels of NPSH, the EF5 and mercury
orange images were visualized in two separate but linked
digitized channels on the system monitor. Rectangles measuring
300 ´ 100 mm were drawn on the EF5 image in areas that
consisted of viable tumour tissue that were either positively
labelled with anti-EF5, or uniformly EF5-negative. To eliminate
bias these regions were selected without reference to the mercury
orange image. Because mercury orange fluorescence was much
higher in tumour tissue compared to stroma, it was possible to
set a threshold level that masked only tumour cells. The corre-
sponding relative fluorescence intensity was then obtained. This
was expressed as mean integrated optical density (IOD), on a
greyscale of zero (black) to 1024 (white). Background due to auto-
fluorescence and instrument noise was obtained by examining
unstained slides fixed in 90% acetone, and subtracted from the
mercury orange IOD values. For each tumour a total of ten
hypoxic and ten oxygenated regions was examined.
RESULTS
Characterization of ME180 and SiHa xenografts
Histological examination of tissue sections stained with haema-
toxylin and eosin showed keratinizing, well-differentiated cervical
squamous cell carcinoma in the ME180 xenografts, with very little
necrosis. The SiHa xenografts also showed typical features of
squamous cell carcinoma, but compared to the ME180 tumours
these were poorly differentiated tumours containing areas of
necrosis. Immunohistochemical staining for metallothionein,
which is usually the most abundant protein sulphydryl in
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in the ME180 and SiHa xenografts.
Mapping hypoxic microregions by EF5 IHC
Composite images showing representative examples of ME180
and SiHa xenografts are shown in Figure 1. Areas of viable tumour
tissue that were positively labelled with anti-EF5 could be clearly
distinguished from EF5-negative areas in all of the ME180 and
SiHa xenografts examined. Surveying the entire tumour surface
revealed a complex, heterogeneous distribution of hypoxia.
Regions of viable tumour tissue could be identified up to 1 mm
across in which there was little or no EF5-labelling. Other regions
that were morphologically similar in parallel haematoxylin and
eosin sections showed highly evolved patterns of EF5 positivity,
with scalloped bands of hypoxic tissue interspersed with regions of
EF5-negative tumour tissue. In the example of an ME180 tumour
shown in Figure 1, these bands of hypoxic tissue can be seen to
form ovoid structures with diameters of 300–500 mM. These
EF5-positive structures were also apparent in the SiHa tumours,
although less clearly delineated.
Identification of hypoxic microregions by EF5
immunofluorescence
A much slower rate of data acquisition imposed a practical limita-
tion on the extent of tumour tissue that could be examined by the
fluorescence microscopy technique. Based on the results of the
parallel sections stained for EF5 using IHC, regions of viable
tumour tissue were chosen for analysis that included significant
amounts of EF5-positive tissue. As illustrated in Figure 2A, the
pattern of EF5-labelling detected by immunofluorescence corre-
sponded closely to that seen using IHC, with finer detail in terms
of textural features and dynamic range.
Measurement of NPSH using mercury orange
Rinsing the cryostat sections in 500 mM mercuric chloride for 30 s
prior to staining in mercury orange, in order to block free
sulphydryl groups, decreased the fluorescence intensity to that of
the autofluorescence background. This indicates that under the
staining conditions used, mercury orange was specifically
labelling free thiols. Time course experiments using cryostat
sections showed that the mercury orange staining intensity
increased rapidly over the first 5 min, consistent with previous
work showing a high affinity for reactive sulphydryls, followed by
a much slower increase in mercury orange staining which was
probably due to binding to less chemically reactive protein thiols
(Asghar et al, 1975; Thomas et al, 1995). There was no detectable
loss of mercury orange staining during the immunofluorescence
staining procedure using anti-EF5. Examination of tissue sections
stained only with Cy5 conjugated anti-EF5 showed that the 585/
40 nm bandpass filter used to collect mercury orange fluorescence
excluded spillover from Cy5 fluourescence.
Histochemical staining of cryostat sections with mercury orange
was greater in viable tumour tissue compared to necrotic tissue or
stromal tissue. As can be seen in Figure 2B, mercury orange
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Table 1 Me 180 tumours
MO-IOD in EF5-positive MO-IOD in EF5-negative
regionsa regionsa
Mean s.d. Mean s.d. P-valueb
1 361 ±46 168 ±72 < 0.0001
2 394 ±89 275 ±57 < 0.0001
3 314 ±72 221 ±59 0.004
4 222 ±43 128 ±47 < 0.0001
aMercury orange staining in ten EF5-positive and ten EF5-negative regions of
each tumour. bStudent’s t-test.
Table 2 SiHa tumours
MO-IOD in EF5-positive  MO-IOD in EF5-negative
regionsa regionsa
Mean s.d. Mean s.d. P-valueb
1 160 ±29 124 ±14 0.002
2 210 ±16 185 ±18 0.006
3 165 ±37 164 ±44 0.917
4 172 ±18 141 ±9 < 0.001
aMercury orange staining in ten EF5-positive and ten EF5-negative regions
of each tumour. bStudent’s t-test.
A
B
500 mm
Me180-2-EF5
500 mm
Figure 1 Anatomical distribution of hypoxia in ME180 (A) and SiHa (B)
xenografts, measured using immunohistochemical labelling of EF5. Each
image is a composite built up from approximately 100 microscope fields
obtained using a 10´ objective lensstaining tended to be stronger in regions of hypoxia defined by
EF5 binding, although the concordance between the two images
was not exact, with relatively high NPSH values being seen in
some regions of viable tumour tissue that were EF5 negative. The
correlations between hypoxia and NPSH levels were quantified by
measuring the mean optical densities of mercury orange staining
in EF5-positive and EF5-negative regions of four ME180 and four
SiHa tumours. As shown in Tables 1 and 2, hypoxic microregions
of ME180 showed an approximately 50% increase in NPSH levels
compared to EF5-negative regions. This was shown to be highly
significant using Student’s t-test to compare values obtained from
ten EF5-positive and ten EF5-negative regions, randomly selected
from each tumour. A similar trend was observed in the poorly
differentiated SiHa tumours, although this was less pronounced
than in ME180 tumours.
DISCUSSION
Because NPSH can compete with oxygen for radical sites on
DNA, the question of whether there is a systematic relationship
between NPSH levels and hypoxia within solid tumours is of
considerable radiobiological interest. In this paper we describe a
technique for simultaneous in situ measurements of tissue hypoxia
and NPSH levels that can address this question directly. Using this
technique we found significantly greater NPSH levels in hypoxic
microregions relative to better oxygenated regions of xenografts
established from human cervical squamous cell carcinoma lines.
The sulphydryl stain mercury orange reacts more rapidly with
active thiols such as glutathione and cysteine than with protein
sulphydryls, so that under controlled labelling conditions it is
fairly specific for NPSH. We have previously shown that the
staining method used in these experiments gives a fluorescence
intensity that is closely correlated with the biochemically-
determined cellular glutathione content (Thomas et al, 1995).
Using high-performance liquid chromatography we have found
that the cysteine concentrations of ME180 and SiHa xenografts is
< 10% of that of glutathione (unpublished data). Because of its
exposed mercury atom, it is likely that mercury orange can also
bind to metallothionein; a cysteine-rich small protein that is
expressed at high levels in some cells. However, by IHC metal-
lothionein levels were low to undetectable in the ME180 and SiHa
xenografts. Blockade of free thiols with mercuric chloride resulted
in almost complete loss of mercury orange staining, indicating that
binding to other chemical groups is minimal under the conditions
used. Therefore it is likely that the mercury orange staining of the
tumours is mainly due to glutathione.
Because the reaction product between NPSH and mercury
orange is retained during immunofluorescence staining, we were
able to combine NPSH measurements with the detection of
hypoxia using EF5. This fluorinated nitroimidazole undergoes a
series of single electron reductions to reactive intermediaries that
can bind to cellular macromolecules. In the presence of oxygen
these reduction products are back-oxidized to EF5, and no tissue
binding takes place. The partial pressure of oxygen at which bound
metabolites are reduced by half corresponds to oxygen concentra-
tions that are radiobiologically significant (i.e. approximately
5 mmHg) (Lord et al, 1993). Studies using oxygen sensitive
polarographic electrodes have shown that the distribution of
hypoxia within solid tumours is very heterogeneous. The introduc-
tion of IHC techniques based on compounds such as EF5 allows
this heterogeneity to be visualized in the context of tissue architec-
ture. By using a computer-controlled microscope stage and an
image analysis program to fuse together multiple individual fields,
we have been able to survey the distribution of hypoxia throughout
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AB
Figure 2 Double fluorescence labelling for EF5 (A) and NPSH (B). These monochromatic images are composites of 64 individual microscope fields acquired
using a 20´ objective lens, taken from a cryostat section cut parallel to the immunoperoxidase-stained example shown in Figure 1. The area corresponds to the
rectangle marked on Figure 1. For clarity the images have been inverted and contrast-enhanced. The rectangular regions drawn on these images represent an
area measuring 300 ´ 100 mm.the cut surface of the tumour. As seen in Figure 1, this shows a
complex, heterogenous picture, with regions of the tumour
appearing to be uniformly well-oxygenated, interspersed with
regions showing highly evolved patterns of EF5 binding. An
underlying motif is the existence of arcs of anti-EF5 staining
having a radius of approximately 150–250 mM. These probably
represent vascular cords; cylinders of well oxygenated tissue
around a blood vessel, surrounded by a rim of hypoxia beyond the
oxygen diffusion distance in tissue. This pattern is particularly
seen in the well-differentiated ME180 tumours.
Hypoxic regions of ME180 tumours showed significantly
higher NPSH values than oxygenated regions. A similar effect was
seen in three of the four SiHa tumours examined, although tech-
nically these were more difficult to study because of the presence
of necrotic tissue interspersed among viable tumour tissue,
and because the EF5-positive regions tended to be less clearly
delineated than in the ME180 tumours. The most likely explana-
tion for these findings is that glutathione levels are increased in
hypoxic regions of the tumours, since the other potential candidate
molecules cysteine and metallothionein are present at low levels in
these two tumours.
Increases in cellular glutathione content have been observed
during tumour cell growth in multicellular spheroids (Romero
et al, 1997), and following exposure of cells to hypoxia followed
by reoxygenation in vitro (O’Dwyer et al, 1994). In this paper we
now provide evidence that glutathione levels can also be increased
in association with hypoxia in vivo. It is not clear from our experi-
ments, or from the previously published data, if these increases in
glutathione are the direct result of hypoxia, or occur in response
to oxidative stress that can occur as a result of acute hypoxia
followed by reoxygenation. The effects of glutathione and other
NPSH on in vitro radiation sensitivity are relatively small under
aerobic conditions, but become more significant under hypoxia
(Bump et al, 1992). The increases in NPSH associated with
hypoxia in cervical cancer xenografts might therefore be sufficient
to produce clinically relevant increases in radiation resistance in
vivo.
We next plan to study biopsy samples obtained from cervix
cancer patients treated in an upcoming clinical trial of EF5, in
order to establish if increased NPSH values are also seen in
hypoxic regions of primary human cancers. Future laboratory
studies will investigate the underlying mechanisms of the increase
in NSPH seen in hypoxic regions of cervical cancer xenografts,
and test if thiol-modulating agents such as buthionine sulphox-
imine show differential effects on hypoxic versus oxic micro-
regions of solid tumours.
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